Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
暂无分享,去创建一个
J. Blay | S. Rodenhuis | M. van Glabbeke | J. Radford | J. Verweij | A. Le Cesne | P. Lorigan | P. Hogendoorn | M. Leahy | Z. Pápai | A. Kirkpatrick | M. V. Van Glabbeke